Educational Videos

ACR 2021 Congress Review Webinar
Developed by CESAS Medical, under the auspices of the University of Glasgow This activity is supported by unrestricted educational grants from Lilly

01 December 2021 
Estimated time to complete activity: 1 hour 36 minutes
Compatible with all modern internet browsers and mobile devices

EDUCATIONAL OBJECTIVES
After completing this activity, the learner will:

• Understand the modes of action of JAK inhibitors in RAli>

• Understand the latest clinical safety and efficacy data of JAK inhibitors from ACR 2021

• Discuss other key highlights from ACR 2021

TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved in treating patients with inflammatory disease.

PROGRAMME OVERVIEW
ACR 2021 presented new scientific and clinical information on cytokine signalling science that will shape the rheumatology treatment landscape. Data presented included new data on the role of JAK inhibitors in the treatment paradigm for rheumatoid arthritis.

In this activity, ACR 2021 Congress Review Webinar, international experts review and discuss key abstracts and data from ACR 2021 JAK inhibitors and the management of rheumatoid arthritis in clinical practice

INSTRUCTIONS FOR PARTICIPATION
Participants must 1) read the activity information; 2) study the educational activity; 3) successfully complete the post-module assessments with a score of 80% or better; 4) and complete the evaluation form. Upon completion of the full activity, your certificate will be made available to download and print.

DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.